Latest HPV Vaccine Available on China's Mainland
Residents of the China's mainland now have access to a nine-way HPV (human papilloma virus) vaccine, which protects against up to nine types of HPV. The China Drug Administration approved the vaccine for market on April 28.
It became the third HPV vaccine approved for the mainland market since the middle of last year. Such vaccines have proved effective against cervical cancer, the second-most common form of cancer among Chinese women aged 15 to 44, after breast cancer. China records approximately 130,000 new cases of cervical cancer each year, and those cases account for more than 28 percent of the world's total new cases.